Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2Sign in
← Cases

EPHA3

RBC: EPHA3 · Substrate: pEY + Mn · high confidenceReferenceDerived

Top inhibitors

MeasuredDerived
DrugInhibition %Gini
Dasatinib100.00.70
Ponatinib97.80.53
Bosutinib95.50.55
Ripretinib87.70.67
Repotrectinib86.80.61
Cabozantinib86.20.75
Nilotinib76.00.77
Tivozanib69.40.67
Crizotinib61.50.58
Erdafitinib54.50.74
Fostamatinib54.00.61
Vandetanib53.00.72
Canertinib47.20.67
Regorafenib31.10.72
Afatinib26.10.71

Known variants

No variants catalogued.
Open in new tab